FOLD Financial Facts

Loss from operations: -44.94M
Restructuring charges: 11K
See Full Income Statement

Total Liabilities and Stockholders' Equity: 918.18M
Accounts payable and accrued expenses: 29.01M
See Full Balance Sheet

Amicus Therapeutics, Inc. (FOLD) Earnings

  |   Expand Research on FOLD
Next EPS Date 2/7/17 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -24.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +10.1% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/15 Q215 -$0.27-$0.24 -$0.03N/A$130K N/A Details
3/3/15 Q414 -$0.24-$0.18 -$0.06N/A$390K N/A Details
5/4/11 Q111 -$0.39-$0.35 -$0.04$6M$1.24M N/A Details
8/9/16 Q216 -$0.40-$0.33 -$0.07N/A$170K N/A Details
2/13/12 Q411 -$0.25-$0.37 +$0.12$922K$6.06M N/A Details
2/14/11 Q410 -$0.48-$0.15 -$0.33$922K$9M N/A Details
11/7/16 Q316 -$0.33-$0.34 +$0.01$2.1M$1.71M N/A Details
5/5/15 Q115 -$0.35-$0.21 -$0.14N/A$250K N/A Details